featured
Cabozantinib for Advanced Neuroendocrine Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
N. Engl. J. Med 2024 Sep 16;[EPub Ahead of Print], JA Chan, S Geyer, T Zemla, MV Knopp, S Behr, S Pulsipher, FS Ou, AC Dueck, J Acoba, A Shergill, EM Wolin, TR Halfdanarson, B Konda, NA Trikalinos, B Tawfik, N Raj, S Shaheen, N Vijayvergia, A Dasari, JR Strosberg, EC Kohn, MH Kulke, EM O'Reilly, JA MeyerhardtFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.